Sign In

Gareth Lewis

Vice President, Specialty Brands at Mayne Pharma

Professional Background

Gareth Lewis is a distinguished pharmaceutical executive with over two decades of extensive experience in research, development, and pharmaceutical commercialization. He has effectively navigated various roles within the pharmaceutical industry, bringing a wealth of knowledge and strategic insight. Gareth's professional journey is marked by his commitment to driving growth and innovation, with a focus on commercial P&L responsibilities, pre-commercialization processes, and comprehensive clinical development.

With a versatile background that encompasses a diverse range of therapeutic areas, Gareth has worked on multiple products utilizing various drug delivery technologies. His strategic development initiatives have been instrumental in fostering sustainable growth within organizations. One of his key focuses has been corporate development, where he has honed his skills in enterprise mergers and acquisitions (M&A), strategic planning, and conducting thorough due diligence. He excels in opportunity evaluation, deal structuring, contract negotiations, and effective transaction and integration processes.

Gareth's expertise extends beyond corporate development to encompass business development as well. He has a proven track record in identifying and cultivating new partnerships, managing contracts, and nurturing long-term relationships for both in- and out-licensing opportunities. His ability to adeptly handle global portfolio management of specialty, branded generic, generic, and over-the-counter (OTC) product opportunities further underscores his comprehensive understanding of the pharmaceutical landscape.

Education and Achievements

Gareth's educational background lays a strong foundation for his successful career in pharmaceuticals. He earned a PhD in Chemistry from the prestigious University of Bristol, which equips him with deep knowledge in scientific principles that are vital to the field of pharmaceutical development. Additionally, he holds a Bachelor of Science (Hons) degree in Chemistry, also from the University of Bristol. This academic foundation has not only shaped Gareth's analytical abilities but also enables him to approach complex problems with innovative solutions.

Organizational Contributions

Throughout his career, Gareth has made significant contributions to various reputable organizations, primarily at Mayne Pharma where he has held several key leadership roles. As the Vice President of Specialty Brands, and formerly as the Vice President of Commercial Development and Vice President of Business Integration, he has played a critical role in orchestrating successful business strategies and overseeing the integration of new assets into the company's portfolio.

Gareth previously served as the Director of Corporate and Business Development at Mayne Pharma, where he led efforts in enhancing the company’s strategic initiatives. His journey at Mayne Pharma also includes positions as Portfolio Manager and Global Program Manager, where his contributions have led to impressive advancements in product offerings and business operations.

Before his tenure with Mayne Pharma, Gareth worked as the Drug Development Manager and Project Manager at Starpharma, where he gained firsthand experience in drug development processes. He also contributed his scientific expertise as a Senior Scientist at AstraZeneca, a leading global biopharmaceutical company known for its innovation. Furthermore, Gareth's academic endeavors include his role as a Lecturer in Inorganic Chemistry at The University of Nottingham, showcasing his commitment to education and mentorship in the scientific community.

With a keen interest in research, he was honored with the Royal Society Postdoctoral Fellowship at the University of New South Wales, where he further explored his passion for chemistry and its applications in the pharmaceutical field.

Achievements

Gareth Lewis has a distinguished track record of achievements throughout his career, characterized by his adeptness in transforming strategic vision into tangible outcomes. He has demonstrated excellence in leading comprehensive business transformations, orchestrating transactions that benefit both companies and stakeholders. His ability to evaluate opportunities effectively has set him apart as a leader in corporate development.

His strong negotiation skills and relationship management have been fundamental in establishing key partnerships that have accelerated growth and innovation. This capability is particularly evident in his experience with contract negotiations and global portfolio management, where he effectively maximized the value of products across various therapeutic areas.

In addition to his professional achievements, Gareth's educational background and teaching experiences have allowed him to inspire and guide a new generation of scientists. He has contributed to the advancement of knowledge in chemistry, empowering students and peers alike to push boundaries in the scientific domain.

Gareth Lewis stands as a testament to excellence in the pharmaceutical industry, merging scientific expertise with sharp business acumen. His journey exemplifies a commitment to innovation, growth, and impactful leadership in pharmaceutical research and development.

Related Questions

How did Gareth Lewis leverage his academic background in Chemistry to achieve success in pharmaceutical commercialization?
What strategies has Gareth Lewis implemented to enhance business growth during his tenure at Mayne Pharma?
In what ways has Gareth Lewis contributed to the advancement of drug delivery technologies in the pharmaceutical industry?
How has Gareth Lewis’s experience in corporate development influenced his approach to mergers and acquisitions?
What are some notable partnerships that Gareth Lewis has established throughout his career?
G
Add to my network

Location

Raleigh, North Carolina